Sugi Predict

Sugi Predict / Compounds / SCHEMBL759802

SCHEMBL759802

SCHEMBL759802

COC(=O)C1(C(=O)OC)CCCC1

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.54
▸ CYP4F2 P78329 1/20 0.44
▸ CYP4A11 Q02928 1/20 0.44
▸ MAPT P10636 1/20 0.40
▸ CYP3A4 P08684 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4870814 0.97 NPSR1 (0.52) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL594374 0.97 NPSR1 (0.52) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL9806699 0.97 NPSR1 (0.52) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL230256 0.94 NPSR1 (0.48) NPSR1CYP4F2CYP4A11MAPTCYP3A4
Ethylene SCHEMBL11214910 0.93 NPSR1 (0.48) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL225044 0.88 NPSR1 (0.46) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL12462298 0.88 NPSR1 (0.46) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL757321 0.87 NPSR1 (0.48) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL30683834 0.87 NPSR1 (0.48) NPSR1CYP4F2CYP4A11MAPTCYP3A4
SCHEMBL5276890 0.85 NPSR1 (0.47) NPSR1CYP4F2CYP4A11MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117210834-A Electrochemical-based promotion of CO 2 Method for synthesizing dicarboxylic acid compound 四川大学 2023-12-12 — — CN disclosed
CN-114957030-B Chiral cyclic compound and preparation method and application thereof 中国科学院化学研究所 2023-09-22 — — CN disclosed
CN-114957030-A Chiral cyclic compound and preparation method and application thereof 中国科学院化学研究所 2022-08-30 — — CN disclosed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 — — EP disclosed
US-9340522-B2 Pyrazolone-derivatives and their use as PDE-4 inhibitors TAKEDA GMBH (DE) 2016-05-17 — — US disclosed
CN-103958533-B Optically active bisoxazoline compound, asymmetric catalyst, and method for producing optically active cyclopropane compound using same SUMITOMO CHEMICAL CO.,LTD. (JP) 2016-02-10 — — CN disclosed
EP-2356103-B1 NOVEL PYRAZOLONE-DERIVATIVES AND THEIR USE AS PDE4 INHIBITORS TAKEDA GMBH (DE) 2015-08-26 — — EP disclosed
EP-2781522-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUND, ASYMMETRIC CATALYST, AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANE COMPOUND USING SAID CATALYST Sumitomo Chemical Company, Limited (JP) 2014-09-24 — — EP disclosed
US-8759365-B2 Organic compounds NOVARTIS AG (CH) 2014-06-24 — — US disclosed
US-8759365-B2 Organic compounds NOVARTIS AG (CH) 2014-06-24 — — US disclosed
US-7276496-B2 Cyclic malonamides as inhibitors of Aβ protein protection BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-10-02 — — US disclosed
US-20070112201-A1 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-17 — — US disclosed
EP-1698617-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENE BISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF Sumitomo Chemical Company, Limited (JP) 2006-09-06 — — EP disclosed
US-20060160802-A1 Peptide deformylase inhibitors GLAXO GROUP LIMITED 2006-07-20 — — US disclosed
US-20060149077-A1 Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-06 — — US disclosed
WO-2006023821-A2 LIGANDS FOR ALDOKETOREDUCTASES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2006-03-02 — — WO disclosed
EP-1593674-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-11-09 — — EP disclosed
WO-2005005456-A2 PEPTIDE DEFORMYLASE INHIBITORS GLAXO GROUP LIMITED (GB) 2005-01-20 — — WO disclosed
US-5532386-A CATALYTIC CARBONIC ESTER AND A TERTIARY AMINE BASF AKTIENGESELLSCHAFT (DE) 1996-07-02 — — US disclosed
US-5412120-A Catalytic decarboxylation of corresponding geminal dicarboxylic acid BASF AKTIENGESELLSCHAFT (DE) 1995-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060149077-A1 Optically active bisoxazoline compounds, process for production of the same and use thereof ACSL3, ADSL, SQLE NPSR1 1062/4885CYP4F2 204/4885CYP4A11 233/4885
US-20070112201-A1 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof CYP3A7, GRK7, CYP2A7 NPSR1 2494/4885CYP4F2 232/4885CYP4A11 421/4885
US-20060160802-A1 Peptide deformylase inhibitors PDF, PEPD, DPEP1 NPSR1 3037/4885CYP4F2 4042/4885CYP4A11 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.